These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Rationale for chemotherapy of tuberculosis and current recommendations. Kumar L Indian Pediatr; 1992 Nov; 29(11):1337-9. PubMed ID: 1294486 [No Abstract] [Full Text] [Related]
46. [Place of bacteriological examination in the treatment of tuberculosis]. Gyselen A Acta Tuberc Pneumol Belg; 1972; 63(4):405-8. PubMed ID: 4206438 [No Abstract] [Full Text] [Related]
47. [Treatment of lepromatous Hansen disease with a rifampicine-isoprodian association (author's transl)]. Colin M; de Montaigne E Med Trop (Mars); 1980; 40(2):157-9. PubMed ID: 6991851 [TBL] [Abstract][Full Text] [Related]
49. [Long-term results of treatment for drug-resistant pulmonary tuberculosis in socially adapted patients]. Khodashova ML; Iuditskiĭ MV; Semenova OV Probl Tuberk Bolezn Legk; 2004; (3):26-8. PubMed ID: 15338896 [TBL] [Abstract][Full Text] [Related]
50. Antileprosy drugs, pregnancy and fetal outcome. Bhargava P; Kuldeep CM; Mathur NK Int J Lepr Other Mycobact Dis; 1996 Dec; 64(4):457-8. PubMed ID: 9030117 [No Abstract] [Full Text] [Related]
51. The effectiveness of a 9-month regimen of isoniazid alone versus 3- and 4-month regimens of isoniazid plus rifampin for treatment of latent tuberculosis infection in children: results of an 11-year randomized study. Spyridis NP; Spyridis PG; Gelesme A; Sypsa V; Valianatou M; Metsou F; Gourgiotis D; Tsolia MN Clin Infect Dis; 2007 Sep; 45(6):715-22. PubMed ID: 17712755 [TBL] [Abstract][Full Text] [Related]
52. [Rifampicin in the treatment of chronic pulmonary tuberculosis]. Pacheco CR; Cordero O; Sierra D; Pacheco J; Vázquez E Gac Med Mex; 1976 Jun; 107(6):505-11. PubMed ID: 976671 [No Abstract] [Full Text] [Related]
54. [Preventive chemotherapy in tuberculosis]. Schönian U; Schmidt M; Ringelmann R Immun Infekt; 1986 Nov; 14(6):208-9. PubMed ID: 3804366 [No Abstract] [Full Text] [Related]
55. SCREENING OF DRUGS FOR TRIAL IN HUMAN LEPROSY. MAYER RL Bibl Tuberc; 1964; 19():219-324. PubMed ID: 14271076 [No Abstract] [Full Text] [Related]
56. A preliminary report on the use of B663 in the treatment of Chinese leprosy patients with chronic reaction. Warren AG Lepr Rev; 1968 Apr; 39(2):61-6. PubMed ID: 5653308 [No Abstract] [Full Text] [Related]
57. Public Health Reports, December 11, 1942: Sulfanilamide in the treatment of leprosy. Faget GH; Johansen FA; Ross H Public Health Rep; 1975; 90(6):486-9. PubMed ID: 813257 [No Abstract] [Full Text] [Related]
58. Streptomycin and INAH in the treatment of leprosy. A preliminary communication. Karat AB; Rao PS; Karat S; Job CK Lepr Rev; 1967 Jul; 38(3):163-70. PubMed ID: 6045748 [No Abstract] [Full Text] [Related]
59. RO-4-4393--A LONG ACTING SULPHONAMIDE IN TREATMENT OF LEPROSY: PRELIMINARY REPORT. GHOSH S; CHAKRABORTY BK Bull Calcutta Sch Trop Med; 1964 Jan; 12():33. PubMed ID: 14154277 [No Abstract] [Full Text] [Related]
60. Sulfanilamide in the treatment of leprosy. 1942. Faget GH; Johansen FA; Sister Hilary Ross Public Health Rep; 2006; 121 Suppl 1():221-3; discussion 220. PubMed ID: 16550782 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]